| Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Y Cao, J Wang, F Jian, T Xiao, W Song, A Yisimayi, W Huang, Q Li, ... Nature 602 (7898), 657-663, 2022 | 1635 | 2022 |
| BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection Y Cao, A Yisimayi, F Jian, W Song, T Xiao, L Wang, S Du, J Wang, Q Li, ... Nature 608, 593-602, 2022 | 1097 | 2022 |
| Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution Y Cao, F Jian, J Wang, Y Yu, W Song, A Yisimayi, J Wang, R An, X Chen, ... Nature 614 (7948), 521-529, 2023 | 527 | 2023 |
| ACE2 binding and antibody evasion in enhanced transmissibility of XBB. 1.5 C Yue, W Song, L Wang, F Jian, X Chen, F Gao, Z Shen, Y Wang, X Wang, ... The Lancet Infectious Diseases 23 (3), 278-280, 2023 | 233* | 2023 |
| Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75 Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu, A Yisimayi, P Wang, ... Cell host & microbe 30 (11), 1527-1539. e5, 2022 | 131 | 2022 |
| Fast evolution of SARS-CoV-2 BA. 2.86 to JN. 1 under heavy immune pressure S Yang, Y Yu, Y Xu, F Jian, W Song, A Yisimayi, P Wang, J Wang, J Liu, ... The Lancet Infectious Diseases 24 (2), e70-e72, 2024 | 118 | 2024 |
| Antigenicity and infectivity characterisation of SARS-CoV-2 BA. 2.86 S Yang, Y Yu, F Jian, W Song, A Yisimayi, X Chen, Y Xu, P Wang, J Wang, ... The Lancet Infectious Diseases 23 (11), e457-e459, 2023 | 82 | 2023 |
| Further humoral immunity evasion of emerging SARS-CoV-2 BA. 4 and BA. 5 subvariants F Jian, Y Yu, W Song, A Yisimayi, L Yu, Y Gao, N Zhang, Y Wang, F Shao, ... The Lancet Infectious Diseases 22 (11), 1535-1537, 2022 | 75 | 2022 |
| Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting A Yisimayi, W Song, J Wang, F Jian, Y Yu, X Chen, Y Xu, S Yang, X Niu, ... Nature 625 (7993), 148-156, 2024 | 67* | 2024 |
| Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents Y Cao, F Jian, Z Zhang, A Yisimayi, X Hao, L Bao, F Yuan, Y Yu, S Du, ... Cell reports 41 (12), 2022 | 60 | 2022 |
| Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding F Jian, L Feng, S Yang, Y Yu, L Wang, W Song, A Yisimayi, X Chen, Y Xu, ... PLoS Pathogens 19 (12), e1011868, 2023 | 33* | 2023 |
| Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution W Ma, H Fu, F Jian, Y Cao, M Li Nature Ecology & Evolution 7 (9), 1457-1466, 2023 | 24 | 2023 |
| Neutralizing antibody evasion and receptor binding features of SARS-CoV-2 Omicron BA. 2.75 Y Cao, Y Yu, W Song, F Jian, A Yisimayi, C Yue, R Feng, P Wang, L Yu, ... Biorxiv 2022, 2007.2018. 500332, 2022 | 14 | 2022 |
| Omicron BA. 2 specifically evades broad sarbecovirus neutralizing antibodies Y Cao, A Yisimayi, F Jian, T Xiao, W Song, J Wang, S Du, Z Zhang, P Liu, ... BioRxiv, 2022.02. 07.479349, 2022 | 11 | 2022 |
| Highly sensitive single-cell chromatin accessibility assay and transcriptome coassay with METATAC H Wu, X Li, F Jian, A Yisimayi, Y Zheng, L Tan, D Xing, XS Xie Proceedings of the National Academy of Sciences 119 (40), e2206450119, 2022 | 8 | 2022 |
| Simultaneous single-cell three-dimensional genome and gene expression profiling uncovers dynamic enhancer connectivity underlying olfactory receptor choice X Xie, H Wu, J Zhang, F Jian, J Chen, Y Zheng, L Tan | 5 | 2023 |
| Antigenicity assessment of SARS-CoV-2 saltation variant BA. 2.87. 1 S Yang, Y Yu, F Jian, A Yisimayi, W Song, J Liu, P Wang, Y Xu, J Wang, ... Emerging Microbes & Infections 13 (1), 2343909, 2024 | 3 | 2024 |
| Comprehensive epitope mapping of broad sarbecovirus neutralizing antibodies Y Cao, A Yisimayi, F Jian, T Xiao, W Song, J Wang, S Du, Z Zhang, P Liu, ... | 2 | 2022 |
| Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity P Liu, C Yue, B Meng, T Xiao, S Yang, S Liu, F Jian, Q Zhu, Y Yu, Y Ren, ... National Science Review, nwae206, 2024 | | 2024 |
| Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences W Ma, H Fu, F Jian, Y Cao, M Li National Science Review, nwae196, 2024 | | 2024 |
Yunlong CaoPeking Univeristy在 pku.edu.cn 的电子邮件经过验证
